Naproxeno Labesfal

Naproxen, the active ingredient in Naproxeno Labesfal, is a nonsteroidal anti-inflammatory drug (NSAID) presented as an oral formulation for systemic use. It is employed to relieve pain, reduce inflammation, and lower fever in adult patients with musculoskeletal, rheumatic and menstrual conditions.

GNH USA supplies Naproxeno Labesfal as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Naproxeno Labesfal, an NSAID, acts on inflammatory pathways to manage several painful and febrile conditions. - Pain (acute musculoskeletal pain): provides analgesic relief by decreasing prostaglandin‑mediated sensitisation of nociceptors. - Osteoarthritis: reduces joint inflammation and improves functional mobility. - Rheumatoid arthritis: helps control chronic synovial inflammation and associated pain. - Dysmenorrhea: alleviates menstrual cramps through uterine prostaglandin inhibition. - Fever: lowers elevated body temperature by acting on the hypothalamic heat‑regulation centre.

Naproxen may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Gastrointestinal upset: nausea, dyspepsia, or abdominal discomfort. - Headache: mild to moderate intensity. - Dizziness: transient sensation of light‑headedness. - Rash: mild skin erythema or itching.

Serious or Rare Side Effects: - Gastrointestinal bleeding or ulceration. - Cardiovascular events such as myocardial infarction or stroke. - Severe skin reactions, including Stevens‑Johnson syndrome. - Renal impairment or acute kidney injury. - Hepatic injury presenting as jaundice or elevated liver enzymes.

Before initiating therapy, consider the following safety measures. - Assess gastrointestinal risk: evaluate history of ulcers or bleeding before use. - Monitor renal function: check serum creatinine in patients with kidney disease. - Avoid in known hypersensitivity: discontinue if allergic reactions occur. - Use the lowest effective dose: limit duration to the shortest period necessary. - Caution with anticoagulants: evaluate bleeding risk when combined with warfarin or similar agents. - Store at ambient temperature: keep below 25 °C, in the original packaging, protected from moisture and direct sunlight.

Naproxen can interact with several drug classes, requiring careful management.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased risk of serious bleeding. - Selective COX‑2 inhibitors: additive cardiovascular toxicity. - High‑dose aspirin: heightened gastrointestinal adverse effects.

Moderate Interactions (Monitor Closely): - ACE inhibitors or diuretics: possible reduction in renal perfusion. - Lithium: naproxen may raise serum lithium levels, necessitating monitoring.